SyMBaD ("Synapses: from Molecules to higher Brain function and Diseases") deals with the study of synapses and extends from molecules through higher brain function to diseases.
The SyMBaD international and research program is part of the Marie Curie Initial Training Network. It particularly aims to better understand the structure and function of the synapse in the normal and the pathological brain.
...
6 private companies : Amplitude systèmes (FR),BioXtal (CH),Explora Nova (FR),GSK (UK),Neurosearch (DK), Noscira (SP)
...